Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Dubinsky

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Inflammatory Bowel Diseases|February 4, 2016
Transition of Inflammatory Bowel Disease Care: Assessment of Transition Readiness Factors and Disease Outcomes in a Young Adult PopulationDanya Rosen, Rachel Annunziato, Jean Frederic Colombel, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 28, 2022
Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children: Expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric CommitteeAmelia Kellar, Michael Dolinger, Kerri L Novak, et al.
Digestive Diseases and Sciences|January 4, 2016
The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune ResponseSarah Sheibani, Russell Cohen, Sunanda Kane, et al.
JAMA Neurology|May 1, 2018
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel DiseaseInga Peter, Marla Dubinsky, Susan Bressman, et al.
Advances in Therapy|January 11, 2017
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by AgeVijay Yajnik, Nabeel Khan, Marla Dubinsky, et al.
Advances in Therapy|June 27, 2023
Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's DiseaseMarla Dubinsky, Christopher Ma, Jenny Griffith, et al.
Crohn'S & Colitis 360|October 15, 2024
Evaluation of the Symptoms and Clinical Characteristics of Crohn's Disease and Ulcerative Colitis That Affect Healthcare Providers' Treatment ChoicesTheresa Hunter Gibble, Carolyn Sweeney, Daniel Wolin, et al.
Nature Reviews. Gastroenterology & Hepatology|January 31, 2025
Understanding the therapeutic toolkit for inflammatory bowel diseaseSophie Vieujean, Vipul Jairath, Laurent Peyrin-Biroulet, et al.
Crohn'S & Colitis 360|March 20, 2023
Crohn's Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative StudyNoelle Rohatinsky, Sandra Zelinsky, Michael Dolinger, et al.
Crohn'S & Colitis 360|January 21, 2025
Exit Interviews Exploring Patients' Experience of Change in Crohn's Disease Symptoms During the Mirikizumab Phase 3 Clinical Trial In Adult Patients With Moderately-to-Severely Crohn's DiseaseTheresa Hunter Gibble, Jake Macey, Harriet Makin, et al.
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Inflammatory Bowel Diseases|February 4, 2016
Transition of Inflammatory Bowel Disease Care: Assessment of Transition Readiness Factors and Disease Outcomes in a Young Adult PopulationDanya Rosen, Rachel Annunziato, Jean Frederic Colombel, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 28, 2022
Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children: Expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric CommitteeAmelia Kellar, Michael Dolinger, Kerri L Novak, et al.
Digestive Diseases and Sciences|January 4, 2016
The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune ResponseSarah Sheibani, Russell Cohen, Sunanda Kane, et al.
JAMA Neurology|May 1, 2018
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel DiseaseInga Peter, Marla Dubinsky, Susan Bressman, et al.
Advances in Therapy|January 11, 2017
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by AgeVijay Yajnik, Nabeel Khan, Marla Dubinsky, et al.
Advances in Therapy|June 27, 2023
Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's DiseaseMarla Dubinsky, Christopher Ma, Jenny Griffith, et al.
Crohn'S & Colitis 360|October 15, 2024
Evaluation of the Symptoms and Clinical Characteristics of Crohn's Disease and Ulcerative Colitis That Affect Healthcare Providers' Treatment ChoicesTheresa Hunter Gibble, Carolyn Sweeney, Daniel Wolin, et al.
Nature Reviews. Gastroenterology & Hepatology|January 31, 2025
Understanding the therapeutic toolkit for inflammatory bowel diseaseSophie Vieujean, Vipul Jairath, Laurent Peyrin-Biroulet, et al.
Crohn'S & Colitis 360|March 20, 2023
Crohn's Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative StudyNoelle Rohatinsky, Sandra Zelinsky, Michael Dolinger, et al.
Crohn'S & Colitis 360|January 21, 2025
Exit Interviews Exploring Patients' Experience of Change in Crohn's Disease Symptoms During the Mirikizumab Phase 3 Clinical Trial In Adult Patients With Moderately-to-Severely Crohn's DiseaseTheresa Hunter Gibble, Jake Macey, Harriet Makin, et al.
Pageof 16